Search results
Is CRISPR Therapeutics a Millionaire Maker?
Motley Fool via Yahoo Finance· 4 hours agoOf particular interest is the CTX211 program for type 1 diabetes, which is currently in phase 1 trials. CTX211 aims to treat or perhaps even effectively...
Experts demand obesity action to cure sick note Britain after diabetes surge
Daily Express· 18 hours agoExperts are demanding a “tough love” crackdown on obesity to cure sick note Britain after a report...
WATCH: Novo Nordisk faces another fire
Euronews via Yahoo News· 2 hours agoThe second fire the company has faced in less than a week. The fire had started outside but later spread to an office building at the company's Bagsvaerd...
Use of Wegovy and other weight-loss drugs soars among kids and young adults
KOLR - KSFX Ozarks· 2 hours agoAt 17, Israel McKenzie was so burdened by obesity that he stopped going to high school in person and...
Click Therapeutics picks up Better's app assets in diabetes, obesity
FierceBiotech· 3 hours agoThe purchase aims to jump-start Click’s work in obesity, diabetes and chronic cardiometabolic...
Exercise, therapy and diet can all improve life during cancer treatment and boost survival
Medical Xpress· 49 minutes agoOn the positive side, medical treatments for cancer are advancing very rapidly. Survival rates are...
Young people’s use of diabetes and weight loss drugs is up 600 percent
Science News· 2 hours agoYoung people’s use of diabetes and weight loss drugs like Ozempic and Wegovy is surging, especially...
Eli Lilly's diabetes drug tirzepatide gets approval in China
Reuters via Yahoo News· 1 day agoSHANGHAI (Reuters) -Eli Lilly said on Tuesday its diabetes drug tirzepatide has received approval...
Obesity fuels 39% rise in diabetes among under-40s, report warns
Press Association News via AOL· 18 hours agoThere has been a 39% rise in cases of diabetes among the under-40s, with poor diets and obesity...
US FDA staff flags risk of low blood sugar for Novo Nordisk's weekly insulin
Reuters via Yahoo News· 4 hours ago(Reuters) -The U.S. Food and Drug Administration's staff said on Wednesday the use of Novo Nordisk's...